CN101254267B - Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like - Google Patents
Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like Download PDFInfo
- Publication number
- CN101254267B CN101254267B CN2007100361194A CN200710036119A CN101254267B CN 101254267 B CN101254267 B CN 101254267B CN 2007100361194 A CN2007100361194 A CN 2007100361194A CN 200710036119 A CN200710036119 A CN 200710036119A CN 101254267 B CN101254267 B CN 101254267B
- Authority
- CN
- China
- Prior art keywords
- gram
- cervicitis
- herb
- drug
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 201000010099 disease Diseases 0.000 title claims abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 16
- 206010046782 Uterine enlargement Diseases 0.000 title abstract 3
- 206010068402 Cervix inflammation Diseases 0.000 title 1
- 238000011282 treatment Methods 0.000 claims abstract description 21
- 206010008323 cervicitis Diseases 0.000 claims abstract description 16
- 208000006374 Uterine Cervicitis Diseases 0.000 claims abstract description 14
- 230000003628 erosive effect Effects 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 210000004392 genitalia Anatomy 0.000 claims abstract description 8
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 3
- 239000009636 Huang Qi Substances 0.000 claims abstract description 3
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 208000032843 Hemorrhage Diseases 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000004576 sand Substances 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 206010028024 Mouth haemorrhage Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 4
- 210000004291 uterus Anatomy 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 3
- 239000002574 poison Substances 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 230000003902 lesion Effects 0.000 abstract 3
- 206010046788 Uterine haemorrhage Diseases 0.000 abstract 2
- 230000001788 irregular Effects 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 241000729173 Cirsium japonicum Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 235000000336 Solanum dulcamara Nutrition 0.000 abstract 1
- 241000193241 Solanum dulcamara Species 0.000 abstract 1
- 235000002594 Solanum nigrum Nutrition 0.000 abstract 1
- 240000002307 Solanum ptychanthum Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 238000001784 detoxification Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- -1 oral liquor Substances 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 201000003988 chronic cervicitis Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical group CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating cervicitis, cervical erosion, hypertrophy of uterus, nodular change and other organic lesions of genital organs with irregular uterine bleeding. Most of the clinical treatments of cervicitis, cervical erosion and other diseases adopt external treatment methods, which can only treat the symptoms, but can not treat the root causes of diseases. The medicine realizes that evil-poison and blood stasis are root causes for the evolution of the diseases from the treatments of numerous cases and proposes that the organic lesions of the gynecological genital organs can be fundamentally cured by combining the removal of the blood stasis on the basis of detoxification (anti-bacterial and anti-inflammation). The drug of the invention is composed of thirteen medicines of glabrous greenbrier rhizome, bittersweet herb, black nightshade herb, Chinese brake herb, heartleaf houttuynia herb, agrimony, barbed skullcap herb, Japanese thistle herb, red paeony root, nutgrass galingale rhizome, membranous milkvetch root, liquoric root, himalayan teasel root and so on according to a certain proportion. With the functions of removing toxicity, eliminating blood stasis, clearing uterus and strengthening vital qi, the drug has immediate efficacy for cervicitis, cervical erosion, hypertrophy of uterus, nodular change and other organic lesions of genital organs with the irregular uterine bleeding, and the long-term clinical practices prove that the drug has special efficacy. The drug can be prepared into a decoction, which can also be prepared into pills, oral liquor, granules, tablets, capsules and other products.
Description
Technical field
The present invention is a kind of medicine for the treatment of the genitals of gynecological organic diseases such as cervicitis, uterine erosion, metrauxe, tuberosity change and scrambling metrorrhagia.
Chronic cervicitis often has connective tissue proliferation and edema, the hypertrophy to such an extent as to the uterus becomes, and comparable normal uterus is big 3～4 times.The morbidity of chronic cervicitis, uterine erosion and uterus carcinoma has certain relation.(selecting from " practical obstetrics and gynecology ")
The cervical cancer finding has erosive type, nodular type, ulcer type, fungating type.Reproduction organic diseases such as cervicitis, cervical erosion, metrauxe, cervical polyp, hysteromyoma are many with the scrambling colporrhagia.(selecting from " traditional Chinese medical science oncology ")
Background technology
" Chinese patent medicine application manual " fuyanping capsules: form by Fructus Cnidii, Radix Sophorae Flavescentis, Ramulus Et Folium Picrasmae, Borneolum Syntheticum, Mentholum, be the gynecological external use medicament, cure mainly vulvitis, vaginitis, cervicitis.
" Chinese patent medicine application manual " KANGGONGYAN PIAN: form by Folium Callicarpae Formosanae, Herba Leonuri, the Radix Linderae.Cure mainly cervicitis, uterine erosion.
Summary of the invention
This doctor comforms and recognizes in the multiple-case treatment: this type of disease is many makes a bet because of damp and hot or evil poison, treatment in time or thoroughly cure, and evil poison causes the stasis of blood, and the malicious stasis of blood is condensed, and develops through delay, and genitals's organic disease such as cervicitis takes place.
Diseases such as treatment cervicitis, cervical erosion, doctor trained in Western medicine does not have specific drugs, adopts 10% silver nitrate to be coated with outward and electricity is consoled, electricity irons, laser, external treatment such as freezing, but must get rid of canceration before the treatment, and is if canceration is arranged, then non-suitable.Traditional Chinese medical science tradition method of treatment is also more adopts the medicine external application, and treatment is extremely inconvenient, and external therapy mostly is and cures the symptoms, not the disease, and is difficult to reach the purpose of healing.This class organic disease is how hemorrhage with scrambling clinically, in the inquiring, the blood stasis of the somewhat block darkish complexion of overwhelming majority patient reflection flows down, this phenomenon fully confirmed the malicious stasis of blood that this doctor proposes condense due to this argument, reach fundamentally and cure, must be in detoxifcation (being the anti-inflammation of doctor trained in Western medicine), in conjunction with removing blood stasis, with trouble without offspring.
Medicine is by Rhizoma Smilacis Glabrae 10-30 gram,, 13 herbal medicines compatibility compositions in the prescribed dose scope such as Herba Solani Lyrati 10-30 gram, Herba Solani Nigri 10-30 gram, Herba Pteridis Multifidae 10-30 gram, cirsii japonici,radix 10 grams, Herba Houttuyniae 10-30 gram, Agrimony 15-30 gram, Herba Scutellariae Barbatae 10-30 gram, Radix Paeoniae Rubra 10 grams, Rhizoma Cyperi 10 grams, Radix Astragali 6-20 gram, Radix Glycyrrhizae 3-10 gram, Radix Dipsaci 10 grams.
This medicine has the function that detoxifcation removing blood stasis, the clearing heat in the pericardium are set upright, and organ matter sexually transmitted disease (STD)s such as cervicitis, uterine erosion, metrauxe, tuberosity change are become and companion's scrambling metrorrhagia has the curative effect of getting instant result.These class case 58 examples of statistics treatment in the period of one nine nine seven, effective percentage 96.4%, cure rate 82.1%.
The specific embodiment
One, this medicine can be made into traditional decoction, and every day, potion was decocted in water for oral dose, implementation example:
Model case 1: Lee so-and-so, the woman, 42 years old, knotweed Jiang Zhenhua Rong Pu people from village of Zixing City, examine one nine nine seven on November 3, one: the vagina scrambling Shi Liangnian that bleeds, in 1995 through the B ultrasonic diagnosis of Zixing City health center for women and children: metrauxe.JIUYUE was diagnosed through the color ultrasound diagnosis of Hunan Province tumour hospital on the 12nd once more in one nine nine seven years: the diffusivity tuberosity changes in the metrauxe, flesh layer.Through the many places treatment, symptom fails to control.Inspection is with a haggard face, green around the gills, and voice are humble.Inquiring: lower abdominal distention pain, the time accompany the block blood stasis of black, purulent leukorrhea, amount is many, shape such as putrid egg thing, abnormal smells from the patient is stench, malaise.Disease belongs to vital QI being weakened and pathogen being violent, and the malicious stasis of blood is stagnant, controls with the detoxifcation removing blood stasis, and the clearing heat in the pericardium is set upright.This prescription drug is made the decoction treatment.
The decoction manufacture method is as follows: the medicine potion is put into the sand jar add clean water, to flood medicine degree of being, soaked 30 minutes, set fire then and use slow fire (little fire) after boiling with high heat on the stove instead and continue and boil 20 minutes, dose decocts two to three times, and merging is boiled liquid and is divided into twice, sooner or later taking medicine before meal.
The patient treated 80 days with this medicine, and the state of an illness is controlled, and menstrual cycle is normal, and its diet is improved, and body constitution is restored, and one stage of treatment is continued in the back, and the state of an illness reaches recent healing, went out to do manual work for many years, and the state of an illness does not recur.
Model case 2: Luo, woman, 42 years old, space word ore deposit, Zixing City families of workers and staff were checked diagnosis in 1993: cervical hypertrophy, upperlip redness through maternity ﹠ child care center, Zixing City, the severe erosion, in October, 1997 is through Chenzhou City the People's Hospital row electric cautery and cooperate the western modern medicine treatment, and the state of an illness is not effectively controlled, postoperative whenever has atropurpureus blood and slime to flow down to menstruation, through after dripping unclean, many with leucorrhea amount, yellow skin, abdominal pain in menstruation, waist weighs down pain, medical history 12 years.Transferred my clinic on the 28th in one nine nine seven years Decembers and use treatment by Chinese herbs instead,, control with clearing away heat-damp and promoting diuresis through damp and hot, the malicious stasis of blood retardance of dialectical genus uterus, the detoxifcation removing blood stasis is made the decoction treatment through this medicine, and every day, potion was decocted in water for oral dose, through controlling three months, examine check through B ultrasonic and woman, to confirm recovery from illness.
Two, except that making decoction, can also get, extract its effective ingredient by quenching, through further being processed into polytype products such as traditional pill, oral liquid, granule, capsule, tablet.With granule production is example, and its technological process of production is as follows:
Selection → cut into slices, chop up → boil carry add in the pot drinking water soak → decoct by boiling lifting manipulation that to get the dried cream of liquid → be condensed into or an amount of Icing Sugar mixing of effective component extracting → pulverizings → addings → with 95% ethanol for twice be wetting agent, make sol particle → drying → with 14-16 sieve shaping → dry or place 30 spend below the packing of oven dry → product, pack and put in storage.
Claims (3)
1. treat genitals's organic disease and the hemorrhage oral medicinal herb agent of scrambling such as cervicitis, uterine erosion, metrauxe, tuberosity change for one kind, by compatible combination in Rhizoma Smilacis Glabrae 10-30 gram, Herba Solani Lyrati 10-30 gram, Herba Solani Nigri 10-30 gram, Herba Pteridis Multifidae 10-30 gram, cirsii japonici,radix 10 grams, Herba Houttuyniae 10-30 gram, Agrimony 15-30 gram, Herba Scutellariae Barbatae 10-30 gram, Radix Paeoniae Rubra 10 grams, Rhizoma Cyperi 10 grams, Radix Astragali 6-20 gram, Radix Glycyrrhizae 3-10 gram, Radix Dipsaci 10 grams, 13 flavor Chinese crude drugs and the above dosage range, through being processed into Oral preparation.
2. the processing technology feature for the treatment of the hemorrhage Chinese medicine decoction of genitals's organic diseases such as cervicitis, uterine erosion, metrauxe, tuberosity change and scrambling according to one kind of claim 1 is: the potion Chinese crude drug is put into clean sand jar, add clean water and be degree to flooding medicine, soaked 30 minutes, set fire and use slow fire after boiling with high heat on the stove instead and continue and boil 20 minutes, dose decocts two to three times.
3. according to claim 1 treatment cervicitis, uterine erosion, metrauxe, the hemorrhage oral medicinal herb granule processing technology feature of genitals's organic diseases such as tuberosity change and scrambling is as follows: selection → section, chop up → according to its proportion compatibility of above prescription, by required amount of formulation put into boil carry pot add a drinking water soak → decoct by boiling lifting manipulation that to get liquid → the be condensed into an amount of Icing Sugar mixing of dried cream → pulverizings → addings → with 95% ethanol for twice be wetting agent, make sol particle →. drying → with 14-16 is sieved shaping → dry or is placed and dries below 30 degrees centigrade.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100361194A CN101254267B (en) | 2007-11-13 | 2007-11-13 | Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100361194A CN101254267B (en) | 2007-11-13 | 2007-11-13 | Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101254267A CN101254267A (en) | 2008-09-03 |
| CN101254267B true CN101254267B (en) | 2011-04-20 |
Family
ID=39889590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100361194A Expired - Fee Related CN101254267B (en) | 2007-11-13 | 2007-11-13 | Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101254267B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885950B (en) * | 2012-10-19 | 2013-12-04 | 岳本兰 | Pharmaceutical composition for treating cervix uteri postoperative bleeding |
| CN103263622B (en) * | 2013-01-25 | 2014-09-10 | 汪秀芹 | Drug for treatment of uterine hypertrophy |
| CN103599371B (en) * | 2013-11-14 | 2016-01-20 | 隋海秀 | A kind of Chinese medicine composition for the treatment of acute cervicitis |
| CN104324185A (en) * | 2014-10-30 | 2015-02-04 | 张立 | Traditional Chinese medicine composition for treating leukorrhagia and preparation method thereof |
| CN104784590A (en) * | 2015-04-23 | 2015-07-22 | 龚灿锋 | Traditional Chinese medicine for treating chronic cervicitis |
| CN104784489B (en) * | 2015-04-28 | 2016-10-05 | 陈红 | A kind of chronic cervicitis for the treatment of merges the Chinese medicine preparation of HPV infection |
| CN104758627B (en) * | 2015-04-30 | 2018-03-16 | 李秀玲 | It is a kind of to treat the Chinese medicine preparation for not producing type chronic cervicitis |
| CN105381452A (en) * | 2015-11-16 | 2016-03-09 | 游莲莲 | Pharmaceutical composition for treating hypertrophy of uterus caused by blood heat and preparation method of pharmaceutical composition |
| CN110302304A (en) * | 2019-08-12 | 2019-10-08 | 南京依美生物科技有限公司 | A kind of gynecological gel preparation and preparation method thereof for treating cervical hypertrophy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413683A (en) * | 2002-11-13 | 2003-04-30 | 贵州和仁堂药业有限公司 | Medicine for treating gynecopathy |
-
2007
- 2007-11-13 CN CN2007100361194A patent/CN101254267B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413683A (en) * | 2002-11-13 | 2003-04-30 | 贵州和仁堂药业有限公司 | Medicine for treating gynecopathy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101254267A (en) | 2008-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254267B (en) | Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like | |
| CN102727832B (en) | Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof | |
| CN101564521A (en) | External plaster for treating hyperplasia of mammary glands | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN103393989B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104399039A (en) | Medicament for treating ulcerative colitis and preparation method thereof | |
| CN103800842A (en) | Traditional Chinese medicine composition for treating carcinoma of urinary bladder | |
| CN104645249B (en) | One kind treats treating coronary heart disease and angina pectoris | |
| CN110613777A (en) | Traditional Chinese medicine composition for treating phlegm-damp stagnation type polycystic ovarian syndrome | |
| CN103405573B (en) | Osteoporosis and bone strengthening formula for treating osteoporosis and preparation process thereof | |
| CN101780231A (en) | Traditional Chinese medicine for treating damp-heat infertility and preparation method thereof | |
| CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN103784574B (en) | A kind of Chinese medicine for oral administration preventing and treating hemolytic disease of newborn | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN102580032A (en) | Chinese medicinal composition tablets, powder and oral liquid with effect of promoting urinary calculus removal and preparation method thereof | |
| CN106581576A (en) | Traditional Chinese medicine composition for protecting liver and promoting gallbladder | |
| CN104815204A (en) | Medicine for treating chronic pelvic inflammation | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN105497404A (en) | Oral metrorrhagia treating traditional Chinese medicine decoction | |
| CN103341058B (en) | Traditional Chinese medicine for treating horse ascites | |
| CN104435362A (en) | Traditional Chinese medicine compound for treating chronic pelvic inflammation | |
| CN103230565A (en) | Blood stasis type obstruction treatment traditional Chinese medicine preparation | |
| CN103656199A (en) | Traditional Chinese medicine for treating cough caused by kidney Yin deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20111113 |